A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer

NCT04856631 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Cancer

Interventions

DRUG: Toripalimab Injection
DRUG: Cetuximab Solution for infusion

Sponsor

Shanghai Junshi Bioscience Co., Ltd.